{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:27:56Z","timestamp":1792182476833,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijrobp.2022.06.063","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:13:47Z","timestamp":1655464427000},"page":"416-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-8389","authenticated-orcid":false,"given":"Carryn M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarinthia E.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal E.","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitali","family":"Nangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Kovoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voichita","family":"Bar-Ad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Abhinand V.","family":"Pedadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Holmlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9 Suppl","key":"10.1016\/j.ijrobp.2022.06.063_bib0001","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0003","series-title":"Advances in Inorganic Chemistry","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0898-8838(06)59007-5","article-title":"Structure-activity studies and the design of synthetic superoxide dismutase (SOD) mimetics as therapeutics","author":"Riley","year":"2006"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2016.10.010","article-title":"Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy","volume":"10","author":"Doskey","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2017.10.019","article-title":"Phase 1b\/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma","volume":"100","author":"Anderson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0006","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1200\/JCO.19.01507","article-title":"Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer","volume":"37","author":"Anderson","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0007","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","article-title":"Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis","volume":"32","author":"Uno","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0008","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1200\/JCO.1993.11.6.1124","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients","volume":"11","author":"LeVeque","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0009","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.freeradbiomed.2020.07.032","article-title":"The novel SOD mimetic GC4419 increases cancer cell killing with sensitization to ionizing radiation while protecting normal cells","volume":"160","author":"El Mahdy","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0010","doi-asserted-by":"crossref","first-page":"eabb3768","DOI":"10.1126\/scitranslmed.abb3768","article-title":"Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide","volume":"13","author":"Sishc","year":"2021","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0011","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hed.25369","article-title":"Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study","volume":"41","author":"Van der Geer","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0012","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/hed.26120","article-title":"Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update","volume":"42","author":"Karsten","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0013","doi-asserted-by":"crossref","unstructured":"Anderson CM, Lee CM, Kelley JR, et al. Roman: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC). J Clin Oncol 2022;40(16_suppl):6005. doi: 10.1200\/JCO.2022.40.16_suppl.6005.","DOI":"10.1200\/JCO.2022.40.16_suppl.6005"},{"key":"10.1016\/j.ijrobp.2022.06.063_bib0014","doi-asserted-by":"crossref","unstructured":"Saunders D, Lee C, Kelley J, et al. Roman: Phase 3 trial of avasopasem to reduce chemoradiotherapy (CRT)-related severe oral mucositis (SOM) in patients with head and neck cancer (HNC). Support Care Cancer 2022;30(Suppl 1):S66. doi: 10.1007\/s00520-022-07099-y.","DOI":"10.1007\/s00520-022-07099-y"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:01:12Z","timestamp":1759744872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622006083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0360301622006083"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.063","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}